Related Experiment Videos

Streptococcal myositis and tissue necrosis with intramuscular administration of diclofenac (Voltaren)

T Rygnestad1, A M Kvam

  • 1Department of Anaesthesia, Regional and University Hospital, Trondheim, Norway.

Insights

A rare case of severe group A beta-haemolytic streptococci infection led to rapid muscle necrosis and death. This highlights the risks of intramuscular injections, particularly non-steroid anti-inflammatory drugs, in cases of skin trauma.

Area of Science:

  • Infectious Diseases
  • Toxicology
  • Pathology

Background:

  • Group A beta-haemolytic streptococci (GABHS) infections can lead to severe complications.
  • Intramuscular drug administration carries potential risks, including localized tissue damage.
  • The Nicolau syndrome is a rare adverse reaction associated with drug injections, often involving non-steroid anti-inflammatory drugs (NSAIDs).

Observation:

  • A patient developed extensive muscle necrosis following intramuscular injections of diclofenac (Voltaren) and metoclopramide (Primperan) after minor skin trauma.
  • The patient's condition rapidly deteriorated, leading to circulatory collapse within 48 hours.
  • Overwhelming septicaemia caused by GABHS was the probable cause of death.

Findings:

  • This case illustrates a potential link between intramuscular injections and the rapid progression of streptococcal myositis.
  • Muscle necrosis, a known but rare side effect of intramuscular drugs (Nicolau syndrome), was observed.
  • GABHS infection was identified as the primary driver of the fatal outcome.

Implications:

  • Healthcare providers should be aware of the potential for severe GABHS infections following minor trauma, especially when combined with intramuscular injections.
  • The risk of Nicolau syndrome, particularly with NSAIDs, warrants careful consideration in clinical practice.
  • Prompt diagnosis and management of suspected streptococcal myositis are critical due to its high mortality rate.

Related Concept Videos